Dr. Comander is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
243 Charles St
Boston, MA 02114Phone+1 617-573-3529
Education & Training
Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Surgical Retina and Vitreous, 2010 - 2012- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolResidency, Ophthalmology, 2007 - 2010
Brigham and Women's HospitalInternship, Internal Medicine, 2006 - 2007
Harvard Medical SchoolClass of 2006
Certifications & Licensure
MA State Medical License 2010 - 2026- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Enhanced Career Development Award Foundation Fighting Blindness
- K12 Mentored Clinical Scientist Development Program Award NIH / National Eye Institute, 2012
- Career Development Award Research for Prevention of Blindness
Publications & Presentations
PubMed
- 274 citationsCytosine and adenine base editing of the brain, liver, retina, heart and skeletal muscle of mice via adeno-associated virusesJonathan M. Levy, Wei-Hsi Yeh, Nachiket D. Pendse, Jessie Rose Davis, Erin Hennessey
Nature Biomedical Engineering. 2020-01-14 - 18 citationsCharacterizing variants of unknown significance in rhodopsin: A functional genomics approach.Aliete Wan, Emily Place, Eric A. Pierce, Jason Comander
Human Mutation. 2019-08-01 - 11 citationsBiallelic RP1-associated retinal dystrophies: Expanding the mutational and clinical spectrum.Rachel M. Huckfeldt, Florin Grigorian, Emily Place, Jason Comander, Demetrios G. Vavvas
Molecular Vision. 2020-06-03
Journal Articles
- Moving Towards PDE6A Gene Supplementation TherapyJason Comander, MD, JAMA Ophthalmology
- Moving Towards PDE6A Gene Supplementation TherapyJason Comander, MD, JAMA Ophthalmology
Press Mentions
Clinical Challenges: Treating Leber Congenital AmaurosisNovember 29th, 2021
CRISPR Used Inside a Person’s Body for the First Time EverMarch 6th, 2020
CLINICAL TRIAL DOWNLOAD: Phase 1/2a Data on Human Retinal Progenitor Cell TherapyMarch 1st, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
